Share of valid certificates (CEPs) for API quality worldwide by region 2020
As of April 2020, India held over 40 percent of the global Certificates of Suitability of Monographs of the European Pharmacopoeia (CEPs). CEPs are proof of an active pharmaceutical ingredient's quality, and are used for drug approvals. This statistic illustrates the global distribution of currently valid certificates (CEPs) for active pharmaceutical ingredients, by most important countries and regions.
